(Q44400609)

2 December 2017

title

Cost-effectiveness of a transplantation strategy compared to melphalan and prednisone in younger patients with multiple myeloma (English)

1 reference

2 December 2017

Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma (English)

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

23 December 2023

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

23 December 2023

author name string

Ann Benger

3

1 reference

2 December 2017

Deborah Marcellus

4

1 reference

2 December 2017

Ronan Foley

5

1 reference

2 December 2017

Jane Garner

6

1 reference

2 December 2017

Carol Ingram

7

1 reference

2 December 2017

Patricia Haines

8

1 reference

2 December 2017

Nancy Henderson-O'Connor

9

1 reference

2 December 2017

Ralph Meyer

10

1 reference

2 December 2017

C. Tom Kouroukis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691140

23 December 2023

Bernie J. O'Brien

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691140

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691140

23 December 2023

publication date

1 January 2003

1 reference

full work available at URL

2 December 2017

http://www.tandfonline.com/doi/pdf/10.3109/10428190309178811

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

23 December 2023

1 reference

2 December 2017

volume

44

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

29-37

1 reference

Cost-effectiveness of high-dose chemotherapy in first-line treatment of advanced multiple myeloma.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190309178811

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190309178811

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190309178811

The measurement of quality of life in hypertensive patients: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190309178811

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190309178811

Cancer chemotherapy reports

21 January 2018

1

9

1

Osgood E

1960

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Combination chemotherapy for multiple myeloma

23 December 2023

2

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

23 December 2023

3

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma

23 December 2023

4

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

23 December 2023

6

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma

23 December 2023

8

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma

23 December 2023

10

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

23 December 2023

12

5

1475

Trippoli S.

1998

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group

23 December 2023

14

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

A clinical and economic evaluation of red blood cell transfusions in patients receiving cancer chemotherapy

23 December 2023

20

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Canadian Medical Association Journal

23 December 2023

21

154

1501

The Canadian Cost of Transfusion Study Group

publication date

1996

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Cancer chemotherapy reports

23 December 2023

25

50

163

Mantel N

1966

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

Canadian Medical Association Journal

23 December 2023

32

146

473

Laupacis A.

1992

1 reference

https://api.crossref.org/works/10.3109/10428190309178811

23 December 2023

Identifiers

1 reference

2 December 2017

1 reference